High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
Titel:
High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers
Auteur:
Palich, R. Veyri, M. Vozy, A. Marot, S. Gligorov, J. Benderra, M.-A. Maingon, P. Morand-Joubert, L. Adjoutah, Z. Marcelin, A.-G. Spano, J.-P. Barrière, J.